Jones Day utilizes the deep bench strength of its attorneys, and is recognized as a premier choice for transactions in high-tech, fintech, biotech and pharmaceutical industries, the department covers the development, licensing, acquisition and commercialization of key technology and property assets. In Silicon Valley, Ka-On Li co-heads the U.S. team, bringing expertise as an IP and technology lawyer to offer guidance in commercial and licensing transactions across industries including life sciences, medtech, consumer goods, fintech, technology, media and telecommunications. New York’s Warren Nachlis co-leads the team, boasting deep experience in a wide range of IP matters with particular focus on pharma, biotech, medical devices, electronics, media and entertainment. Also in New York, Scott Lyne is lauded for his practice in corporate transactions, licensing and counseling with particular emphasis on life sciences. Adept in matters across tech, information and data assets, San Diego-based lawyer Thomas Briggs handles cross-border work. Also in San Diego, Robert Latta is a recognized authority in negotiating cross-border agreements, with focus on life sciences and environmental sustainability.
Legal 500 Editorial commentary
Accolades
Client satisfaction
Testimonials
Collated independently by Legal 500 research team.
‘The team has excellent industry experience, and they understand the business needs/goals of the client. The advice is always clear and practical. ’
‘Thomas Briggs in San Diego is phenomenal. He asks good questions so he is sure to understand the client's goals and business needs. And he then presents multiple options/solutions to help us get there. He is efficient and truly is a trusted business advisor.’
‘This team knows the law and has seen enough over the years that they know the pitfalls and how to avoid them. They know licensing and its nuances, and their work product is always top notch and performed in the most efficient way possible. ’
‘Tom Briggs knows the law immensely well, and he can draft and revise agreements faster than anyone I have worked with. He listens closely and understands what we need often better than we do. He works so fast that the costs always remain reasonable. I wouldn't work with anyone else.'
Key clients
- Sanofi
- Xyphos Biosciences
- Rich Data Co.
- British American Tobacco
- Cellectis SA
- Kowa Company, Ltd.
- The Procter & Gamble Company
- Centre Lane Partners, LLC
- The Riverside Company
- Five9, Inc.
Work highlights
Represented Sanofi in connection with an exclusive licensing agreement with RadioMedix, Inc., and Orano Med, subsidiary of the Orano Group, focused specifically on the late-stage project, AlphaMedix™ (212Pb-DOTAMTATE) being evaluated for the treatment of adult patients with somatostatin-receptor expressing neuroendocrine tumors (NETs), a rare cancer.
Represented Xyphos Biosciences, Inc. in connection with a research collaboration and license agreement with Kelonia Therapeutics, Inc. under which the companies will combine Kelonia's iGPS® with Xyphos' ACCEL™ technology to develop innovative in vivo CAR-T Cell therapies.
Advised The Procter & Gamble Company in the exclusive licensing and distribution agreement with Newsan S.A. for the commercialization in Argentina of P&G’s Gillette, Pantene, Head & Shoulders, Downy, Vick, and Cebión brands (among others), as well as for the manufacturing and commercialization of Pampers diapers and Always pads.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Ka-on Li; Warren Nachlis
Other key lawyers
Scott Lyne; Thomas Briggs; Robert Latta